-
Record FDI flow into Greece raises bar, but is it sustainable?
-
Balance of payments shows shipping on course for bumper year, but economic benefits unclear
-
One unicorn does not a Silicon Valley make: positive news on startup front also highlights limitations
-
Impact of inflation already widespread, but data suggests worse to come
-
Discussion over PEPP, SGP draw attention to rising yields
-
Post-Covid era dawns on new landscape for bad debt in Greece
Greek health care spending in the spotlight
The world of Greek politics is being consumed by a price-fixing scandal centred on the Swiss pharmaceutical company Novartis, and its alleged links to senior Greek politicians between 2006-2015.
Ten former ministers and prime ministers, most of whom served between 2010 and 2014, are alleged to have accepted a total of 50 million euros in kickbacks from the Greek subsidiary of the pharma giant. The preferential treatment of Novartis is alleged t...
You need a subscription to access our analysis. Please choose one of the packages available.
Full Access
A tailor-made service for professionals
Apart from having access to all our analysis and data, subscribers will be able to consult one-on-one with our analysts.
Free Access
Read some of our analysis for no charge
By signing up to MacroPolis, readers will be able to read two of our articles without charge each month. They will not have access to our data or weekly e-newsletter.
Standard Access
Our analysis and data at your fingertips
Subscribers will be able to read the full range of our articles, access our statistics and charts, and receive our weekly e-newsletter for €450 per year.
€500.00